Menthol amplifies and prolongs nicotine effects in e-cigarette exposure, study finds

Menthol actively reshapes both the intensity and duration of nicotine's effects
A researcher explains why menthol should not be viewed as merely a passive flavoring ingredient in e-cigarettes.
Mark

So menthol just makes nicotine hit harder and last longer? That seems like a pretty big deal for e-cigarette users.

Mimi

That's what the rat data shows, yes. When menthol and nicotine were inhaled together, the body temperature drop—which is how they measured nicotine's effect—lasted significantly longer than with nicotine alone. And the nicotine byproducts in the blood were higher too.

Luke

But this is rats, right? We should be careful about jumping to humans. The physiology is similar in some ways, but not identical.

Mimi

True. That's why the researchers are planning to look at the brain signaling mechanisms next. They want to understand the actual pathway.

Mark

And they only tested males so far?

Mimi

Yes, 81 male rats. The next phase will include females to see if the effect differs by sex.

Luke

That's important because if menthol affects men and women differently, that changes the public health picture entirely.

Mark

So right now we know menthol changes how long and how strong nicotine's effects are, but we don't know why or if it's the same in humans.

Mimi

Exactly. The "why" is the next question. Is it something about how menthol interacts with nicotine in the lungs? Is it in the brain? That's what they're going to investigate.

Luke

And the practical question—does this mean menthol e-cigarettes are more addictive? That's not answered yet.

Mimi

Not directly, no. But if menthol prolongs and intensifies nicotine's effects, it's reasonable to think it could influence dependence. That's the implication worth watching.

  • Scientists found that rats inhaling menthol and nicotine together still showed measurably stronger physiological effects 120 minutes after exposure ended — far outlasting the effects of nicotine alone.
  • The menthol-nicotine combination raised nicotine metabolite levels in the bloodstream, suggesting menthol is altering how the body processes the drug, not just how it tastes.
  • The research challenges regulatory and public assumptions that flavor additives in e-cigarettes are pharmacologically inert — menthol, it turns out, is actively rewriting the drug's profile.
  • Researchers are now pressing forward to map the brain signaling pathways menthol disrupts and to determine whether these effects differ between male and female subjects, a gap that carries significant implications for understanding addiction across sexes.

For decades, menthol has been understood as a flavor — a cooling sensation that makes nicotine products more palatable. New research published in ACS Chemical Neuroscience quietly dismantles that assumption, revealing that menthol actively reshapes how nicotine behaves inside the body, intensifying its effects and extending them well beyond what nicotine alone produces. The finding invites a broader reckoning with how we classify the ingredients we assume are merely cosmetic, and what those assumptions may cost us in terms of addiction and public health.

Menthol has long been treated as a cosmetic ingredient — a cooling agent that makes nicotine products feel smoother and more appealing. But a new study published in ACS Chemical Neuroscience suggests that framing is dangerously incomplete. When menthol and nicotine are inhaled together in e-cigarette aerosol, menthol doesn't simply flavor the experience — it changes the drug itself.

Led by Seong Shoon Yoon and colleagues, the study exposed 81 male rats to controlled e-cigarette aerosols containing either nicotine alone or a menthol-nicotine combination. The researchers tracked body temperature changes — a reliable marker of nicotine's physiological impact in rodents — and measured nicotine byproducts in the bloodstream after exposure.

The results were difficult to dismiss. Rats that inhaled the menthol-nicotine combination showed a prolonged drop in body temperature compared to those exposed to nicotine alone, with significant differences persisting more than 120 minutes after exposure ended. The combination also produced higher concentrations of nicotine metabolites in the blood and made the drug's effects more perceptible to the animals themselves.

Yoon was direct about what this means: menthol is not a passive additive. It actively amplifies nicotine's intensity and extends its duration — a distinction that could have real consequences for how quickly dependence forms and how hard it becomes to quit. The team now plans to investigate the precise brain signaling mechanisms involved and whether the effects hold equally for female rats, a question that matters given the known sex differences in how nicotine affects the body.

Menthol is everywhere in nicotine products—a cooling agent so familiar that most people think of it as nothing more than flavor. But new research suggests it does something far more consequential than make a cigarette or vape feel refreshing. Scientists have found that when menthol and nicotine are inhaled together in e-cigarette aerosol, menthol amplifies nicotine's effects on the body and stretches them out over time, making the drug's impact both stronger and longer-lasting.

The work, published in ACS Chemical Neuroscience, emerged from a controlled study led by Seong Shoon Yoon and colleagues who wanted to understand what happens when these two substances travel into the lungs together. While earlier research had hinted that menthol could influence how the body responds to nicotine, the specifics of their interaction in e-cigarette aerosol remained largely unmapped. The team designed an experiment to fill that gap.

They created their own e-cigarette liquids containing only nicotine and menthol—no other flavorings—and exposed 81 male rats to the aerosols in a controlled chamber. Using a commercial e-cigarette device, they delivered puffs at five-minute intervals, varying the number of puffs depending on what they were testing. After exposure, they measured nicotine and its metabolic byproducts in the rats' blood and tracked changes in body temperature, a reliable marker of how nicotine affects rodents.

The results were striking. When rats inhaled menthol and nicotine together, compared to nicotine alone, the combination prolonged the nicotine-induced drop in body temperature—the two groups still showed significant differences 120 minutes after exposure ended. The menthol-nicotine combination also made nicotine's effects more pronounced to the animals and produced higher levels of nicotine byproducts in their bloodstream. In other words, menthol didn't just change the flavor; it changed the drug itself.

Yoon emphasized the implications of the finding: menthol should not be understood as a passive ingredient, simply there to make the experience more pleasant. Instead, the research in male rats demonstrates that menthol actively reshapes both the intensity and duration of nicotine's effects on the body and on the brain's internal drug-cue responses. This distinction matters because it suggests that menthol-containing e-cigarettes may deliver a different pharmacological experience than their non-menthol counterparts—one that could influence how quickly dependence develops or how difficult it becomes to quit.

The team's next steps are to dig deeper into the mechanism. They want to understand exactly how menthol alters nicotine-related signaling in the brain and whether these effects hold true for female rats as well as males. That question of sex differences is particularly important, since nicotine's effects on the body can vary significantly between men and women, and adding menthol to the equation introduces another layer of complexity. For now, the finding stands as a reminder that the additives we assume are cosmetic often carry hidden pharmacological weight.

Menthol should not be viewed merely as a passive flavor additive. Our findings show that it changes both the intensity and the duration of nicotine's physiological and internal drug-cue effects.
— Seong Shoon Yoon, lead researcher
Quer a matéria completa? Leia o original em News-Medical ↗
Fale Conosco FAQ